Olink
  • Home
  • Products
    See our
    Complete biomarker list
    See the list
    Standard Panels
    • Products Overview
    • Cardiometabolic panel
    • Cell Regulation panel
    • Cardiovascular II panel
    • Cardiovascular III panel
    • Development panel
    • Immune Response panel
    • Immuno-Oncology panel
    • Inflammation panel
    • Metabolism panel
    • Neurology panel
    • Neuro Exploratory panel
    • Oncology II panel
    • Oncology III panel
    • Organ Damage panel
    • Mouse Exploratory panel
    Other Products
    • Custom panels
    • Statistical services
    • Insights Stat Analysis app
    • NPX Manager
  • Analysis Service
    • How our Analysis Service works
    • Analysis Service Uppsala
    • Analysis Service Boston
    • External service providers
  • Data you can trust
    • Why you can trust Olink
    • Our PEA technology
    • Data generation and QC
    • Transparent data validation
    • Publications
    • Customer testimonials
    • Webinars
  • Resources & support
    • Resources & support central
    • Document download center
    • White papers from Olink
    • FAQ
    • Using Olink with other sample matrices
    • Olink with other species
  • About us
    • About Olink Proteomics
    • Contact us
    • Integrity Policy
    • News and events
    • Working at Olink
    • Our vision
    • Press releases

  • About us
  • Contact us
  • Sales Contacts for Europe

  • CONTACT SALES FOR EUROPE


    Andrea Ballagi
    VP Sales and Marketing
    andrea.ballagi@olink.com
    +46 708200635

     

    Nordics


    Carl-Johan Simola
    Nordics Regional Manager
    (starts August 2020)

     


    Hanna Mann
    Business Development Manager, South Sweden and Denmark
    hanna.mann@olink.com
    +46 732366186

     

     

    Southern Europe


    AnnaLotta Schiller Vestergren
    Business Development Manager for Southern Europe
    annalotta.schiller@olink.com
    +46 702667997

     


    Anissa Lamarque
    Business Development Manager for France
    anissa.lamarque@olink.com
    +33 638 444 615

     

    United Kingdom


    Philippa Pettingill
    Field Application Specialist for UK
    philippa.pettingill@olink.com
    +44 7765030046

     

    BeNeLux


    Henk Mouthaan
    Dir. Business Development Central Europe
    henk.mouthaan@olink.com
    +31 623638582

     


    Kate Sokolova
    Business Development Manager BeNeLux
    kate.sokolova@olink.com
    +31 683674486

     

    DACH


    Leonhard Pollack
    Business Development Manager DACH
    leonhard.pollack@olink.com
    +49 176 616 99201

     


    Karsten Strauss
    Business Development Manager DACH
    karsten.strauss@olink.com
    +49 17624085420

     

  • About us – menu

    • Integrity Policy
    • Contact us
      • Sales Contacts for Europe
    • Our vision
    • Working at Olink
    • News and events
    • Press releases
    • Can we help you?

    • Let us know how best to contact you below (email or phone). PLEASE NOTE, include your international dialing code when submitting your phone number!

  • Follow us
    • 1506

    BIOMARKER ASSAYS
    • 173 125 000

    PROTEIN DATA POINTS GENERATED
    • 433

    PUBLICATIONS

Olink Essentials

  • Our Innovation

    Learn more about our technology and how it can meet your biomarker discovery needs

  • Our Products

    Learn more about our growing range of protein biomarker panels

  • Our Transparency

    Learn more about our rigorous assay QC and validation process and see the data

  • Our Expertise

    Learn more about Olink's Analysis Service: our in-house experts are here to run your assays for you

Do you want to know more?

Fill in the form and we will contact you as soon as we can.

Sitemap

  • Welcome to Olink
  • Products
  • Analysis Service
  • Data you can trust
  • Resources & support
  • About us

Contact

    • Email:
    • info@olink.com
    • Phone number:
    • +46 (0)18 - 444 39 70

Social media

  1. Copyright 2020 Olink
  2. Created with by wasabiweb

  • We use cookies to optimize your experience on our website. By choosing to continue, you acknowledge acceptance of our use of cookies. Learn more about cookies here.

  • Do not show this message again